de Mulder PH - Search Results

1

Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group.

Verweij J, Wanders J, Gil T, Schöffski P, Catimel G, te Velde A, de Mulder PH. Verweij J, et al. Among authors: de mulder ph. Br J Cancer. 1996 Feb;73(3):400-2. doi: 10.1038/bjc.1996.69. Br J Cancer. 1996. PMID: 8562350 Free PMC article. Clinical Trial.

2

A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinoma.

De Mulder PH, Cappelaere P, Cognetti F, Verweij J, Schornagel JH, Vermorken JB, Kirkpatrick A, Lefebvre JL. De Mulder PH, et al. Cancer Chemother Pharmacol. 1994;33(5):438-40. doi: 10.1007/BF00686275. Cancer Chemother Pharmacol. 1994. PMID: 8306420 Clinical Trial.

3

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck.

Planting AS, de Mulder PH, de Graeff A, Verweij J. Planting AS, et al. Among authors: de graeff a, de mulder ph. Eur J Cancer. 1997 Jan;33(1):61-5. doi: 10.1016/s0959-8049(96)00311-5. Eur J Cancer. 1997. PMID: 9071901 Clinical Trial.

4

Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group.

Planting AS, Catimel G, de Mulder PH, de Graeff A, Höppener F, Verweij J, Oster W, Vermorken JB. Planting AS, et al. Among authors: de graeff a, de mulder ph. Ann Oncol. 1999 Jun;10(6):693-700. doi: 10.1023/a:1008353505916. Ann Oncol. 1999. PMID: 10442192 Free article. Clinical Trial.

5

Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEP.

de Wit R, Louwerens M, de Mulder PH, Verweij J, Rodenhuis S, Schornagel J. de Wit R, et al. Among authors: de mulder ph. Int J Cancer. 1999 Dec 10;83(6):831-3. doi: 10.1002/(sici)1097-0215(19991210)83:6<831::aid-ijc24>3.0.co;2-o. Int J Cancer. 1999. PMID: 10597204 Clinical Trial.

6

Toxic dermatitis induced by 10-ethyl-10-deaza-aminopterin (10-EdAM), a novel antifolate.

Verweij J, Schornagel J, de Mulder P, Henzen-Logmans S, Cognetti F, Clavel M, Vermorken J. Verweij J, et al. Cancer. 1990 Nov 1;66(9):1910-3. doi: 10.1002/1097-0142(19901101)66:9<1910::aid-cncr2820660909>3.0.co;2-2. Cancer. 1990. PMID: 2224785 Clinical Trial.

7

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

Catimel G, Vermorken JB, Clavel M, de Mulder P, Judson I, Sessa C, Piccart M, Bruntsch U, Verweij J, Wanders J, et al. Catimel G, et al. Ann Oncol. 1994 Jul;5(6):543-7. doi: 10.1093/oxfordjournals.annonc.a058910. Ann Oncol. 1994. PMID: 7918127 Free article. Clinical Trial.

8

Induction chemotherapy with cisplatin and continuous infusion 5-fluorouracil in locally far-advanced head and neck cancer.

Verweij J, de Jong PC, de Mulder PH, van der Broek P, Alexieva-Figusch J, van Putten WL, Schornagel JH, Ravasz LA, Snow GB, Vermorken JB. Verweij J, et al. Among authors: de jong pc, de mulder ph. Am J Clin Oncol. 1989 Oct;12(5):420-4. doi: 10.1097/00000421-198910000-00012. Am J Clin Oncol. 1989. PMID: 2801602

9

Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.

Schornagel JH, Verweij J, de Mulder PH, Cognetti F, Vermorken JB, Cappelaere P, Armand JP, Wildiers J, de Graeff A, Clavel M, et al. Schornagel JH, et al. Among authors: de graeff a, de mulder ph. J Clin Oncol. 1995 Jul;13(7):1649-55. doi: 10.1200/JCO.1995.13.7.1649. J Clin Oncol. 1995. PMID: 7602354 Free article. Clinical Trial.

10

Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC Early Clinical Trials Group.

Bruntsch U, Heinrich B, Kaye SB, de Mulder PH, van Oosterom A, Paridaens R, Vermorken JB, Wanders J, Franklin H, Bayssas M, et al. Bruntsch U, et al. Among authors: de mulder ph. Eur J Cancer. 1994;30A(8):1064-7. doi: 10.1016/0959-8049(94)90457-x. Eur J Cancer. 1994. PMID: 7654430 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters